 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | Anti-CD22 CAR-T Cells / Beijing Boren Hospital, RD102 / IASO BIO
Journal, CAR T-Cell Therapy: A novel full-human CD22-CAR T cell therapy with potent activity against CD22 B-ALL. (Pubmed Central) - Jan 6, 2022
No abstract available